Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?
A. Hernando Sanz, E. Perez Rodriguez, F. Troncoso Acevedo, R. Gomez Garcia, M. Valle Falcones, S. Diaz Lobato, E. Manas, R. Light (Madrid, Spain; Nashville, United States Of America)
Source: Annual Congress 2006 - Epidemiology, clinical features, malignant pleural diseases, treatment
Disease area: Respiratory infections, Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hernando Sanz, E. Perez Rodriguez, F. Troncoso Acevedo, R. Gomez Garcia, M. Valle Falcones, S. Diaz Lobato, E. Manas, R. Light (Madrid, Spain; Nashville, United States Of America). Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?. Eur Respir J 2006; 28: Suppl. 50, 4488
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Incidence and aetiology of eosinophilic pleural effusion Source: Eur Respir J 2009; 34: 1111-1117 Year: 2009
Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007
Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Diagnostic approach in a patient with pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131 Year: 2002
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009
Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110 Year: 2002
Combined use of pleural fluid adenosine deaminase and lymphocyte/ neutrophil ratio for the diagnosis of tuberculous pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 33s Year: 2004
Measurement of pleural fluid lactate dehydrogenase and adenosine deaminase for distinguishing malignant pleural effusions and other exudative pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 246s Year: 2004
Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019
Separating malignant from nonmalignant pleural effusion on the basis of P O2 in pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003